873330-62-2

Basic information

• Product Name: Benzoic acid, 2-amino-3-(phenylethynyl)-, methyl ester
• CAS NO: 873330-62-2
• Molecular Formula: C16H13NO2
• Molecular Weight: 251.285
• Mol File: 873330-62-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-amino-3-(phenylethynyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-amino-3-(phenylethynyl)-, methyl ester(873330-62-2)
• EPA Substance Registry System: Benzoic acid, 2-amino-3-(phenylethynyl)-, methyl ester(873330-62-2)

Safety Data

• Hazardous Substances Data: 873330-62-2(Hazardous Substances Data)

Upstream product

• 104670-74-8 methyl 2-amino-3-bromobenzoate 
• 536-74-3 phenylacetylene 

Downstream Products

• 873330-63-3 2-iodo-3-phenylethynylbenzoic acid methyl ester 
• 873330-64-4 2-[3-naphthylaminopropyl]-3-phenylethynyl-benzoic acid methyl ester 
• 873330-65-5 2-[3-aminopropyl]-3-phenylethynyl-benzoic acid methyl ester 
• 873330-66-6 6-phenylethynyl-2,3,4,5-tetrahydro-benzo[c]azepin-1-one 

Relevant articles and documents

EBNA1 INHIBITORS AND THEIR METHOD OF USE

Pharmaceutical compositions of the invention comprise EBNA1 inhibitors useful for the treatment of diseases caused by EBNA1 activity such as cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis. Pharmaceutical compositions of the invention also comprise EBNA1 inhibitors useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection. Pharmaceutical compositions of the invention also comprise EBNA1 inhibitors useful for the treatment of diseases caused by lytic Epstein-Barr Virus (EBV) infection.